Leukemia. 2012 Apr;26(4):563-71. doi: 10.1038/leu.2011.314. Epub 2011 Nov 11.

Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera.

Reikvam H, Tiu RV.

Hematology. 2011 Nov;16(6):351-6.

Serum levels of endothelium-derived endocan are increased in patients with untreated acute myeloid leukemia.

Hatfield KJ, Lassalle P, Leiva RA, Lindås R, Wendelboe Ø, Bruserud Ø.

Bone Marrow Res. 2011;2011:570796. Epub 2010 Oct 4.

Future perspectives: therapeutic targeting of notch signalling may become a strategy in patients receiving stem cell transplantation for hematologic malignancies.

Ersvaer E, Hatfield KJ, Reikvam H, Bruserud O.

Biol Blood Marrow Transplant. 2012 Feb;18(2):190-9. Epub 2011 Oct 20.

The pretransplantation serum cytokine profile in allogeneic stem cell recipients differs from healthy individuals, and various profiles are associated with different risks of posttransplantation complications.

Reikvam H, Mosevoll KA, Melve GK, Günther CC, Sjo M, Bentsen PT, Bruserud Ø.

J Infect Dis. 2011 Dec;204(11):1779-86. Epub 2011 Oct 11.

Human cellular immune response against Giardia lamblia 5 years after acute giardiasis.

Hanevik K, Kristoffersen E, Svard S, Bruserud O, Ringqvist E, Sørnes S, Langeland N.

Cancer Immunol Immunother. 2011 Dec;60(12):1669-81. Epub 2011 Oct 12.

Future perspectives: should Th17 cells be considered as a possible therapeutic target in acute myeloid leukemia patients receiving allogeneic stem cell transplantation?

Ersvær E, Melve GK, Bruserud O.

Expert Rev Hematol. 2011 Oct;4(5):563-76.

The chemokine system in allogeneic stem-cell transplantation: a possible therapeutic target?

Melve GK, Ersvssr E, Kittang AO, Bruserud O.

Cytotherapy. 2011 Nov;13(10):1259-68. doi: 10.3109/14653249.2011.605117. Epub 2011 Sep 12.

Effects of peripheral blood stem cell apheresis on systemic cytokine levels in patients with multiple myeloma.

Akkök CA, Hervig T, Stamnesfet S, Nesthus I, Melve GK, Lassalle P, Bruserud O.

Leuk Res. 2011 Sep;35(9):1156-8. Epub 2011 Jul 30.

Heat shock protein 90 (HSP90) inhibition in acute myeloid leukemia--targeting of disease heterogeneity through direct and indirect antileukemic effects.

Bruserud Ø, Hatfield KJ, Reikvam H.

J Biomed Biotechnol. 2011;2011:104631. Epub 2011 May 3.

Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications.

Reikvam H, Hatfield KJ, Kittang AO, Hovland R, Bruserud Ø.

Cytotherapy. 2011 Sep;13(8):1013-24. Epub 2011 Apr 20.

Is there a scientific basis for a recommended standardization of collection and cryopreservation of peripheral blood stem cell grafts?

Akkök CA, Liseth K, Melve GK, Ersvaer E, Hervig T, Bruserud Ø.

Oncol Rep. 2011 Jun;25(6):1549-56. doi: 10.3892/or.2011.1229. Epub 2011 Mar 22.

Immunogenic apoptosis in human acute myeloid leukemia (AML): primary human AML cells expose calreticulin and release heat shock protein (HSP) 70 and HSP90 during apoptosis.

Fredly H, Ersvær E, Gjertsen BT, Bruserud O.

Eur Cytokine Netw. 2011 Mar;22(1):52-62.

A prospective observational study of the effect of platelet transfusions on levels of platelet-derived cytokines, chemokines and interleukins in acute leukaemia patients with severe chemotherapy-induced cytopenia.

Apelseth TO, Hervig T, Wentzel-Larsen T, Petersen K, Reikvam H, Bruserud Ø.

Blood Rev. 2011 May;25(3):113-22. Epub 2011 Feb 12.

Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia.

Apelseth TO, Hervig T, Bruserud O.

Blood Cancer J. 2011 Feb;1(2):e4. doi: 10.1038/bcj.2011.2. Epub 2011 Feb 11.

Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemia.

Skavland J, Jørgensen KM, Hadziavdic K, Hovland R, Jonassen I, Bruserud O, Gjertsen BT.

J Proteomics. 2011 Mar 1;74(3):269-81. Epub 2010 Nov 12.

Untangling the intracellular signalling network in cancer--a strategy for data integration in acute myeloid leukaemia.

Jørgensen KM, Hjelle SM, Øye OK, Puntervoll P, Reikvam H, Skavland J, Anderssen E, Bruserud Ø, Gjertsen BT.